Project Grant R21EB035260

Award Date 8/2/24
Completion Date 7/31/26
Dollars Obligated $389K
Federal Grant Program
93.286
Assistance Type
Project Grant
Place of Performance
New Jersey, USA
Similar Awards
This $271,664 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) aims to develop a novel biomaterial delivery platform to spatiotemporally deliver bone morphogenetic proteins (BMP2 and BMP9) to promote regeneration of bone and articular cartilage after digit amputation. Specifically, the project will engineer bioactive, magnetic...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $342,776 Project Grant (CFDA 93.286 - Discovery and Applied Research for Technological Innovations to Improve Human Health) to Rutgers, The State University in New Jersey. The 4-year grant, running from May 2025 to April 2029, aims to develop foundational data science methods and a pipeline for efficient and exceptional monoclonal antibody (mAb) formulation. The project will prototype experimental and data handling...
The National Science Foundation awarded a $750,000 Project Grant to Rutgers, The State University under the Engineering program (CFDA 47.041) from September 1, 2022 to August 31, 2025. The grant funds research to develop an injectable nanoparticle therapy to restore strength and length to damaged tendons and ligaments. Specifically, the university will investigate combining a thermosensitive polymer and crosslinking agent to stabilize joints by quickly strengthening and returning tissues like...
This federal Project Grant award for $1,617,565.00, provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program, supports the development of a "Modular Toolbox of Protein and Lipid Hybrid Biomaterials for siRNA Delivery". The project aims to construct a versatile, multi-functional platform technology, termed "Lipoproteoplex...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA 93.859 Biomedical Research and Research Training program provides $386,190 to Rensselaer Polytechnic Institute (RPI) for the period of August 1, 2024 to May 31, 2029. The project aims to explore the development of new approaches for enhancing the function of biomedical and biological interfaces through self-assembled multifunctional biointerfaces. Key research objectives include: 1) creating...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $214,408 Project Grant under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program to the University of Florida. This 2-year grant, effective May 1, 2025, aims to develop advanced manufacturing processes for ultra-thin, ultra-reliable, and implantable liquid-crystal-polymer-based bioelectronic interfaces. The key focus areas are: 1) Developing a...
This Project Grant award of $406,832.00 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) aims to develop novel boron-dipyrromethene (BODIPY) based photo-uncaging groups. The research will focus on creating efficient red-to-near-infrared (red-to-NIR) light-responsive materials that can enable low-power LED-driven photo-uncaging for applications such as...
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286), provides $198,646 to the Colorado School of Mines to develop machine learning-guided polymeric nanocarriers for efficient and safe delivery of ribonucleoproteins (RNPs) to hematopoietic stem and progenitor cells (HSPCs). The key objectives are to: 1) Engineer...
This federal Project Grant award for $504,888, provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286), supports the development of an engineered biomaterial to improve the survival and integration of human induced pluripotent stem cell-derived neurons (hiPSC-neurons) transplanted for the treatment of spinal cord injury. Specifically, the...
This Project Grant from the National Science Foundation Division of Materials Research provides $418,382 to Rensselaer Polytechnic Institute for research under the Mathematical and Physical Sciences program (CFDA 47.049). The award will fund development of novel implantable biomaterials composed of polymerized prodrugs of 17?-estradiol formulated as oriented electrospun microfibers embedded in an injectable hydrogel matrix. These materials are designed to slowly degrade via hydrolysis...

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $388,575 Project Grant (CFDA 93.286: Discovery and Applied Research for Technological Innovations to Improve Human Health) to Rutgers, The State University in New Jersey. The project aims to develop a platform technology for encapsulating and delivering the bone morphogenic protein 2 (BMP-2) in hydrophobic polymer matrices. Using an active machine learning workflow, the project will optimize the formulation of BMP-2 with stabilizing random heteropolymers to create amphiphilic polymer-protein hybrids that facilitate co-dissolution and even dispersion within the polymer matrix. The resulting microparticles will be evaluated for tunable and sustained BMP-2 release, with the goal of improving methods for encapsulating biologics in hydrophobic drug delivery systems. The project period runs from August 2, 2024 to July 31, 2026.

Generated 6/10/25, 3:09 AM